Literature DB >> 25142291

Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control.

Keith G Rasmussen1.   

Abstract

OBJECTIVE: To assess the psychiatric side effects of ketamine when administered in subanesthetic doses to hospitalized patients. It is hypothesized that such effects occur frequently.
METHODS: In this retrospective study, the medical records of 50 patients hospitalized on medical and surgical units at our facility who had continuous intravenous infusions of ketamine for pain or mild sedation were reviewed. Patient progress in the days following the start of ketamine infusion was reviewed and response to ketamine was noted.
RESULTS: Twenty-two percent of the patients were noted to have some type of psychiatric reaction to ketamine, including agitation, confusion, and hallucinations. These reactions were relatively short lived, namely, occurring during or shortly after the infusions. No association was found between patient response to ketamine and gender, age, or infusion rate.
CONCLUSION: Awareness of the psychiatric side effects of ketamine is an important consideration for clinicians administering this medication either for pain control or for depressive illness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142291     DOI: 10.1017/neu.2013.61

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  9 in total

1.  Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Authors:  Marlene P Freeman; George I Papakostas; Bettina Hoeppner; Erica Mazzone; Heidi Judge; Cristina Cusin; Sanjay Mathew; Gerard Sanacora; Dan Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2019-01-08       Impact factor: 4.791

2.  Ketamine-Induced Hallucinations.

Authors:  Albert R Powers; Mark G Gancsos; Emily S Finn; Peter T Morgan; Philip R Corlett
Journal:  Psychopathology       Date:  2015-09-12       Impact factor: 1.944

Review 3.  Multistage drug effects of ketamine in the treatment of major depression.

Authors:  Martin Walter; Shijia Li; Liliana Ramona Demenescu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-13       Impact factor: 5.270

4.  Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial).

Authors:  Jacob Juel; Søren Schou Olesen; Anne Estrup Olesen; Jakob Lykke Poulsen; Albert Dahan; Oliver Wilder-Smith; Adnan Madzak; Jens Brøndum Frøkjær; Asbjørn Mohr Drewes
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

5.  Could dietary glutamate be contributing to the symptoms of obsessive-compulsive disorder?

Authors:  Kathleen F Holton; Elizabeth W Cotter
Journal:  Future Sci OA       Date:  2018-01-10

Review 6.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

7.  Incidence of Dissociation With Low-Dose Pre-hospital Ketamine in Geriatric Patients With Trauma-Related Pain.

Authors:  Melanie M Randall; Jennifer Raae-Nielsen; Mia Choi; William S Dukes; Timothy Nesper; Michael K Mesisca
Journal:  Cureus       Date:  2022-08-05

8.  Adverse Effects Associated with Patient-Controlled Analgesia with Ketamine Combined with Opioids and Ketamine Infusion with PCA Bolus in Postoperative Spine Patients: A Retrospective Review.

Authors:  Tiffany M Pouldar; Dermot P Maher; Alexander W Betz; Jeffrey J Wiegers; Jeremy A Friedman; Sameer S Zaidi; Ali Rejali; Hai P Tran; Roya Yumul; Charles Louy
Journal:  J Pain Res       Date:  2022-10-10       Impact factor: 2.832

9.  "I Can Remember Sort of Vivid People…but to Me They Were Plasticine." Delusions on the Intensive Care Unit: What Do Patients Think Is Going On?

Authors:  Julie L Darbyshire; Paul R Greig; Sarah Vollam; J Duncan Young; Lisa Hinton
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.